Search

Search Constraints

You searched for: Author/Creator Federico, Massimo

Search Results

11. Combination of rituximab and nonpegylated liposomal doxorubicin (R‐NPLD) as front‐line therapy for aggressive non‐Hodgkin lymphoma (NHL) in patients 80 years of age or older: a single‐center retrospective study. Issue 1 (3rd February 2017)

12. Defining the best cut‐off value for lymphopenia in diffuse large B cell lymphoma treated with immuno‐chemotherapy. (3rd May 2014)

14. Dismal outcome of t‐cell lymphoma patients failing first‐line treatment: results of a population‐based study from the Modena Cancer Registry. Issue 3 (29th April 2014)

15. Distribution of lymphoma subtypes in Ukraine according to the WHO 2016 classification. Issue 1 (19th August 2022)

16. Distribution of Second Primary Malignancies Suggests a Bidirectional Effect Between Breast and Endometrial Cancer: A Population-Based Study. Issue 8 (1st November 2009)

17. Double Hit Lymphoma Diagnosis and Treatment in Europe—A Cross-Sectional Survey of Clinical Practice by the EHA Lymphoma Working Party (EHA LyG). Issue 6 (20th December 2020)

18. Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12*. Issue 1 (2nd January 2017)

19. Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study. (8th November 2018)

20. EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 Pandemic. Issue 2 (27th February 2021)